Antitumor immunity promoted by vascular occluding therapy: Lessons from vascular-targeted photodynamic therapy (VTP)

Photochemical and Photobiological Sciences

Volumn 10, Issue 5, 2011, Pages 681-688

  Preise, Dina ^a   Scherz, Avigdor ^a   Salomon, Yoram ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79955566470     PISSN: 1474905X     EISSN: 14749092     Source Type: Journal    
DOI: 10.1039/c0pp00315h     Document Type: Review

References (72)

1. O. J. Finn Cancer immunology N. Engl. J. Med. 2008 358 2704 2715
2. G. P. Adams L. M. Weiner Monoclonal antibody therapy of cancer Nat. Biotechnol. 2005 23 1147 1157 (Pubitemid 41486396)
3. D. J. Slamon B. Leyland-Jones S. Shak H. Fuchs V. Paton A. Bajamonde T. Fleming W. Eiermann J. Wolter M. Pegram J. Baselga L. Norton Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 N. Engl. J. Med. 2001 344 783 792 (Pubitemid 32222155)
4. J. Copier A. G. Dalgleish C. M. Britten L. H. Finke G. Gaudernack S. Gnjatic K. Kallen R. Kiessling M. Schuessler-Lenz H. Singh J. Talmadge H. Zwierzina L. Hakansson Improving the efficacy of cancer immunotherapy Eur. J. Cancer 2009 45 1424 1431
5. S. Akira K. Takeda T. Kaisho Toll-like receptors: critical proteins linking innate and acquired immunity Nat. Immunol. 2001 2 675 680 (Pubitemid 32747155)
6. A. Lanzavecchia F. Sallusto Regulation of T cell immunity by dendritic cells Cell 2001 106 263 266 (Pubitemid 32772609)
7. A. J. Hayes L. Y. Li M. E. Lippman Science, medicine, and the future. Antivascular therapy: a new approach to cancer treatment Br. Med. J. 1999 318 853 856 (Pubitemid 29191965)
8. M. A. Gimbrone, Jr. S. B. Leapman R. S. Cotran J. Folkman Tumor dormancy in vivo by prevention of neovascularization J. Exp. Med. 1972 136 261 276
9. A. Eberhard S. Kahlert V. Goede B. Hemmerlein K. H. Plate H. G. Augustin Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies Cancer Res. 2000 60 1388 1393 (Pubitemid 30152012)
10. H. F. Dvorak J. A. Nagy J. T. Dvorak A. M. Dvorak Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules Am. J. Pathol. 1988 133 95 109
11. Y. Boucher L. T. Baxter R. K. Jain Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy Cancer Res. 1990 50 4478 4484 (Pubitemid 20230379)
12. J. L. Li A. L. Harris The potential of new tumor endothelium-specific markers for the development of antivascular therapy Cancer Cell 2007 11 478 481 (Pubitemid 46856912)
13. M. M. Cooney W. van Heeckeren S. Bhakta J. Ortiz S. C. Remick Drug insight: vascular disrupting agents and angiogenesis-novel approaches for drug delivery Nat. Clin. Pract. Oncol. 2006 3 682 692 (Pubitemid 44843126)
14. S. Fleshker D. Preise V. Kalchenko A. Scherz Y. Salomon Prompt assessment of WST11-VTP outcome using luciferase transfected tumors enables second treatment and increase in overall therapeutic rate Photochem. Photobiol. 2008 84 1231 1237
15. D. Preise O. Mazor N. Koudinova M. Liscovitch A. Scherz Y. Salomon Bypass of tumor drug resistance by antivascular therapy Neoplasia 2003 5 475 480 (Pubitemid 38045084)
16. A. Scherz, Y. Salomon, H. Scheer, and A. Brandis, Palladium-substituted bacteriochlorophyll derivatives and use thereof., International PC Patent Application No. PCT/IL99/00673., 1999
17. S. Gross A. Gilead A. Scherz M. Neeman Y. Salomon Monitoring photodynamic therapy of solid tumors online by BOLD-contrast MRI Nat. Med. 2003 9 1327 1331 (Pubitemid 37279859)
18. N. V. Koudinova J. H. Pinthus A. Brandis O. Brenner P. Bendel J. Ramon Z. Eshhar A. Scherz Y. Salomon Photodynamic therapy with Pd-Bacteriopheophorbide (TOOKAD): successful in vivo treatment of human prostatic small cell carcinoma xenografts Int. J. Cancer 2003 104 782 789 (Pubitemid 36418518)
19. A. Brandis O. Mazor E. Neumark V. Rosenbach-Belkin Y. Salomon A. Scherz Novel water-soluble bacteriochlorophyll derivatives for vascular-targeted photodynamic therapy: synthesis, solubility, phototoxicity and the effect of serum proteins Photochem. Photobiol. 2005 81 983 993 (Pubitemid 41265068)
20. O. Mazor A. Brandis V. Plaks E. Neumark V. Rosenbach-Belkin Y. Salomon A. Scherz WST11, a novel water-soluble bacteriochlorophyll derivative; cellular uptake, pharmacokinetics, biodistribution and vascular-targeted photodynamic activity using melanoma tumors as a model Photochem. Photobiol. 2005 81 342 351 (Pubitemid 40551511)
21. I. Ashur R. Goldschmidt I. Pinkas Y. Salomon G. Szewczyk T. Sarna A. Scherz Photocatalytic generation of oxygen radicals by the water-soluble bacteriochlorophyll derivative WST11, noncovalently bound to serum albumin J. Phys. Chem. A 2009 113 8027 8037
22. S. R. Davidson R. A. Weersink M. A. Haider M. R. Gertner A. Bogaards D. Giewercer A. Scherz M. D. Sherar M. Elhilali J. L. Chin J. Trachtenberg B. C. Wilson Treatment planning and dose analysis for interstitial photodynamic therapy of prostate cancer Phys. Med. Biol. 2009 54 2293 2313
23. J. Trachtenberg A. Bogaards R. A. Weersink M. A. Haider A. Evans S. A. McCluskey A. Scherz M. R. Gertner C. Yue S. Appu A. Aprikian J. Savard B. C. Wilson M. Elhilali Vascular targeted photodynamic therapy with palladium-bacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: assessment of safety and treatment response J. Urol. 2007 178 1974 1979 (Pubitemid 47554440)
24. Y. Vakrat-Haglili L. Weiner V. Brumfeld A. Brandis Y. Salomon B. McLlroy B. C. Wilson A. Pawlak M. Rozanowska T. Sarna A. Scherz The microenvironment effect on the generation of reactive oxygen species by Pd-bacteriopheophorbide J. Am. Chem. Soc. 2005 127 6487 6497 (Pubitemid 40627771)
25. T. J. Dougherty C. J. Gomer B. W. Henderson G. Jori D. Kessel M. Korbelik J. Moan Q. Peng Photodynamic therapy J. Natl. Cancer Inst. 1998 90 889 905 (Pubitemid 28304157)
26. N. Madar-Balakirski C. Tempel-Brami V. Kalchenko O. Brenner D. Varon A. Scherz Y. Salomon Permanent occlusion of feeding arteries and draining veins in solid mouse tumors by vascular targeted photodynamic therapy (VTP) with Tookad PLoS One 2010 5 e10282
27. M. Korbelik G. J. Dougherty Photodynamic therapy-mediated immune response against subcutaneous mouse tumors Cancer Res. 1999 59 1941 1946 (Pubitemid 29186169)
28. D. Preise R. Oren I. Glinert V. Kalchenko S. Jung A. Scherz Y. Salomon Systemic antitumor protection by vascular-targeted photodynamic therapy involves cellular and humoral immunity Cancer Immunol. Immunother. 2008 58 71 84
29. G. Canti D. Lattuada A. Nicolin P. Taroni G. Valentini R. Cubeddu Antitumor immunity induced by photodynamic therapy with aluminium disulfonated phthalocyanines and laser light Anti-Cancer Drugs 1994 5 443 447 (Pubitemid 24237076)
30. N. Agrawal C. Bettegowda I. Cheong J. F. Geschwind C. G. Drake E. L. Hipkiss M. Tatsumi L. H. Dang L. A. Diaz, Jr. M. Pomper M. Abusedera R. L. Wahl K. W. Kinzler S. Zhou D. L. Huso B. Vogelstein Bacteriolytic therapy can generate a potent immune response against experimental tumors Proc. Natl. Acad. Sci. U. S. A. 2004 101 15172 15177 (Pubitemid 39391737)
31. P. J. Wysocki E. P. Kwiatkowska U. Kazimierczak W. Suchorska D. W. Kowalczyk A. Mackiewicz Captopril, an angiotensin-converting enzyme inhibitor, promotes growth of immunogenic tumors in mice Clin. Cancer Res. 2006 12 4095 4102 (Pubitemid 44078098)
32. X. Huang M. K. Wong H. Yi S. Watkins A. D. Laird S. F. Wolf E. Gorelik Combined therapy of local and metastatic 4T1 breast tumor in mice using SU6668, an inhibitor of angiogenic receptor tyrosine kinases, and the immunostimulator B7.2-IgG fusion protein Cancer Res. 2002 62 5727 5735 (Pubitemid 35204728)
33. A. P. Castano P. Mroz M. X. Wu M. R. Hamblin Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model Proc. Natl. Acad. Sci. U. S. A. 2008 105 5495 5500 (Pubitemid 351753891)
34. E. Kabingu L. Vaughan B. Owczarczak K. D. Ramsey S. O. Gollnick CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells Br. J. Cancer 2007 96 1839 1848 (Pubitemid 46912014)
35. V. H. Fingar W. R. Potter B. W. Henderson Drug and light dose dependence of photodynamic therapy: a study of tumor cell clonogenicity and histologic changes Photochem. Photobiol. 1987 45 643 650
36. S. O. Gollnick L. Vaughan B. W. Henderson Generation of effective antitumor vaccines using photodynamic therapy Cancer Res. 2002 62 1604 1608 (Pubitemid 34408477)
37. A. Ribas J. M. Timmerman L. H. Butterfield J. S. Economou Determinant spreading and tumor responses after peptide-based cancer immunotherapy Trends Immunol. 2003 24 58 61 (Pubitemid 36120639)
38. A. K. Abbas and A. H. Lichtman, Cellular and molecular immunology, Elsevier Saunders, Philadelphia, PA, 5th edn, 2005
39. E. S. Abdel-Hady P. Martin-Hirsch M. Duggan-Keen P. L. Stern J. V. Moore G. Corbitt H. C. Kitchener I. N. Hampson Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy Cancer Res. 2001 61 192 196 (Pubitemid 32095717)
40. P. S. Thong K. W. Ong N. S. Goh K. W. Kho V. Manivasager R. Bhuvaneswari M. Olivo K. C. Soo Photodynamic-therapy-activated immune response against distant untreated tumours in recurrent angiosarcoma Lancet Oncol. 2007 8 950 952 (Pubitemid 47488070)
41. R. M. Zinkernagel H. Hengartner Regulation of the immune response by antigen Science 2001 293 251 253 (Pubitemid 32694732)
42. L. Chen Immunological ignorance of silent antigens as an explanation of tumor evasion Immunol. Today 1998 19 27 30 (Pubitemid 28078605)
43. Y. Lu P. S. Low Targeted immunotherapy of cancer: development of antibody-induced cellular immunity J. Pharm. Pharmacol. 2003 55 163 167 (Pubitemid 36277752)
44. W. R. Chen Z. Huang M. Korbelik R. E. Nordquist H. Liu Photoimmunotherapy for cancer treatment J. Environ. Pathol. Toxicol. Oncol. 2006 25 281 291 (Pubitemid 43341247)
45. F. H. van Duijnhoven R. A. Tollenaar O. T. Terpstra P. J. Kuppen Locoregional therapies of liver metastases in a rat CC531 coloncarcinoma model results in increased resistance to tumour rechallenge Clin. Exp. Metastasis 2005 22 247 253 (Pubitemid 41298006)
46. A. Jalili M. Makowski T. Switaj D. Nowis G. M. Wilczynski E. Wilczek M. Chorazy-Massalska A. Radzikowska W. Maslinski L. Bialy J. Sienko A. Sieron M. Adamek G. Basak P. Mroz I. W. Krasnodebski M. Jakobisiak J. Golab Effective photoimmunotherapy of murine colon carcinoma induced by the combination of photodynamic therapy and dendritic cells Clin. Cancer Res. 2004 10 4498 4508 (Pubitemid 38878894)
47. T. Kushibiki T. Tajiri Y. Tomioka K. Awazu Photodynamic therapy induces interleukin secretion from dendritic cells Int. J. Clin. Exp. Med. 2010 3 110 114
48. S. Jung D. Unutmaz P. Wong G. Sano K. De, los Santos T. Sparwasser S. Wu S. Vuthoori K. Ko F. Zavala E. G. Pamer D. R. Littman R. A. Lang In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens Immunity 2002 17 211 220 (Pubitemid 35245963)
49. B. Chen B. W. Pogue J. M. Luna R. L. Hardman P. J. Hoopes T. Hasan Tumor vascular permeabilization by vascular-targeting photosensitization: effects, mechanism, and therapeutic implications Clin. Cancer Res. 2006 12 917 923 (Pubitemid 43259874)
50. D. E. Dolmans A. Kadambi J. S. Hill C. A. Waters B. C. Robinson J. P. Walker D. Fukumura R. K. Jain Vascular accumulation of a novel photosensitizer, MV6401, causes selective thrombosis in tumor vessels after photodynamic therapy Cancer Res. 2002 62 2151 2156 (Pubitemid 34408464)
51. J. Zilberstein A. Bromberg A. Frantz V. Rosenbach-Belkin A. Kritzmann R. Pfefermann Y. Salomon A. Scherz Light-dependent oxygen consumption in bacteriochlorophyll-serine-treated melanoma tumors: on-line determination using a tissue-inserted oxygen microsensor Photochem. Photobiol. 1997 65 1012 1019 (Pubitemid 127471587)
52. G. L. Semenza Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology Trends Mol. Med. 2001 7 345 350 (Pubitemid 32735019)
53. V. Nizet R. S. Johnson Interdependence of hypoxic and innate immune responses Nat. Rev. Immunol. 2009 9 609 617
54. B. Acosta-Iborra A. Elorza I. M. Olazabal N. B. Martin-Cofreces S. Martin-Puig M. Miro M. J. Calzada J. Aragones F. Sanchez-Madrid M. O. Landazuri Macrophage oxygen sensing modulates antigen presentation and phagocytic functions involving IFN-gamma production through the HIF-1 alpha transcription factor J. Immunol. 2009 182 3155 3164
55. A. Mancino T. Schioppa P. Larghi F. Pasqualini M. Nebuloni I. H. Chen S. Sozzani J. M. Austyn A. Mantovani A. Sica Divergent effects of hypoxia on dendritic cell functions Blood 2008 112 3723 3734
56. S. Mitra S. E. Cassar D. J. Niles J. A. Puskas J. G. Frelinger T. H. Foster Photodynamic therapy mediates the oxygen-independent activation of hypoxia-inducible factor 1alpha Mol. Cancer Ther. 2006 5 3268 3274 (Pubitemid 46092070)
57. Z. Ji G. Yang S. Shahzidi K. Tkacz-Stachowska Z. Suo J. M. Nesland Q. Peng Induction of hypoxia-inducible factor-1alpha overexpression by cobalt chloride enhances cellular resistance to photodynamic therapy Cancer Lett. 2006 244 182 189 (Pubitemid 44485877)
58. M. K. Callahan D. Chaillot C. Jacquin P. R. Clark A. Menoret Differential acquisition of antigenic peptides by Hsp70 and Hsc70 under oxidative conditions J. Biol. Chem. 2002 277 33604 33609
59. C. L. Chiang J. A. Ledermann A. N. Rad D. R. Katz B. M. Chain Hypochlorous acid enhances immunogenicity and uptake of allogeneic ovarian tumor cells by dendritic cells to cross-prime tumor-specific T cells Cancer Immunol. Immunother. 2006 55 1384 1395 (Pubitemid 44187670)
60. L. J. Marnett J. N. Riggins J. D. West Endogenous generation of reactive oxidants and electrophiles and their reactions with DNA and protein J. Clin. Invest. 2003 111 583 593 (Pubitemid 36278574)
61. S. Yla-Herttuala W. Palinski S. W. Butler S. Picard D. Steinberg J. L. Witztum Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL Arterioscler. Thromb. 1994 14 32 40
62. D. M. Wuttge M. Bruzelius S. Stemme T-cell recognition of lipid peroxidation products breaks tolerance to self proteins Immunology 1999 98 273 279 (Pubitemid 29487650)
63. E. Carrasco-Marin J. E. Paz-Miguel P. Lopez-Mato C. Alvarez-Dominguez F. Leyva-Cobian Oxidation of defined antigens allows protein unfolding and increases both proteolytic processing and exposes peptide epitopes which are recognized by specific T cells Immunology 1998 95 314 321 (Pubitemid 28505685)
64. P. Srivastava Roles of heat-shock proteins in innate and adaptive immunity Nat. Rev. Immunol. 2002 2 185 194 (Pubitemid 37328765)
65. B. Javid P. A. MacAry P. J. Lehner Structure and function: heat shock proteins and adaptive immunity J. Immunol. 2007 179 2035 2040
66. C. V. Nicchitta Re-evaluating the role of heat-shock protein-peptide interactions in tumour immunity Nat. Rev. Immunol. 2003 3 427 432 (Pubitemid 37323202)
67. M. Korbelik J. Sun I. Cecic Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response Cancer Res. 2005 65 1018 1026 (Pubitemid 40216464)
68. V. Plaks Y. Posen O. Mazor A. Brandis A. Scherz Y. Salomon Homologous adaptation to oxidative stress induced by the photosensitized Pd-bacteriochlorophyll derivative (WST11) in cultured endothelial cells J. Biol. Chem. 2004 279 45713 45720 (Pubitemid 39491561)
69. M. Korbelik J. Sun Photodynamic therapy-generated vaccine for cancer therapy Cancer Immunol. Immunother. 2005 55 900 909
70. L. Goldshaid E. Rubinstein A. Brandis D. Segal N. Leshem O. Brenner V. Kalchenko D. Eren T. Yecheskel Y. Salitra Y. Salomon A. Scherz Novel design principles enable specific targeting of imaging and therapeutic agents to necrotic domains in breast tumors Breast Cancer Res. 2010 12 R29
71. R. Goldberg, PhD. Thesis, The Weizmann Institute of Science, 2011
72. D. Preise, PhD Thesis, The Weizmann Institute of Science, 2008